Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mark Holodniy MD"'
Autor:
Vilija R. Joyce MS, Huiying Sun PhD, Paul G. Barnett PhD, Nick Bansback PhD, Susan C. Griffin MSc, Ahmed M. Bayoumi MD, Aslam H. Anis PhD, Mark Sculpher PhD, William Cameron MD, Sheldon T. Brown MD, Mark Holodniy MD, Douglas K. Owens MD, MS
Publikováno v:
MDM Policy & Practice, Vol 2 (2017)
Objectives: The Medical Outcomes Study HIV Health Survey (MOS-HIV) is frequently used in HIV clinical trials; however, scores generated from the MOS-HIV are not suited for cost-effectiveness analyses as they do not assign utility values to health sta
Externí odkaz:
https://doaj.org/article/9fb4c555b84743dcab3f11313666ce39
Autor:
Shan Liu PhD, Paul G. Barnett PhD, Mark Holodniy MD, Jeanie Lo MPH, Vilija R. Joyce MS, Risha Gidwani DrPH, Steven M. Asch MD, MPH, Douglas K. Owens MD, MS, Jeremy D. Goldhaber-Fiebert PhD
Publikováno v:
MDM Policy & Practice, Vol 1 (2016)
Background: Chronic hepatitis C viral (HCV) infection affects millions of Americans. Health care systems face complex choices between highly efficacious, costly treatments. This study assessed the cost-effectiveness of treatments for chronic, genotyp
Externí odkaz:
https://doaj.org/article/eba9f6cb2d884e6dbd0ec76771e49d9d
Publikováno v:
Journal of the International Association of Providers of AIDS Care, Vol 13 (2014)
We used the Veterans Health Administration (VA) HIV Clinical Case Registry (CCR) to evaluate the association between annual CD4 averages and all-cause mortality in HIV-infected veterans during their initial episode of suppressive highly active antire
Externí odkaz:
https://doaj.org/article/05a28cc8d1044562b81881f50f3a5eb4